Status:

COMPLETED

The CAROLE (CArdiac Related Oncologic Late Effects) Study

Lead Sponsor:

Northwell Health

Conditions:

Coronary Artery Disease

Cardiac Disease

Eligibility:

FEMALE

26-78 years

Brief Summary

CAROLE seeks to evaluate the relationship between chest Radiation Therapy and coronary artery disease. The purpose of CAROLE is to check the heart health of women who received breast cancer treatment...

Detailed Description

Background: Within the United States, there are an estimated 3.1 million women alive who have been diagnosed with invasive breast cancer, and approximately 56% of them have received radiation. Worldwi...

Eligibility Criteria

Inclusion

  • If you are a breast cancer survivor who was diagnosed between the ages of ≥ 18-65 years (now at age 26-78).
  • It has been at least 6 years since you were diagnosed.
  • If you did not have a diagnosis of heart disease before\* having breast cancer.
  • (\*women diagnosed with heart disease after breast cancer may still be eligible)

Exclusion

  • Patients who are unable to care for themselves or who are unable to come in for testing due to health conditions or incarceration will be rescheduled or removed in the case of chronic ineligibility. No vulnerable patient populations will be used in this study. Patients will be excluded if they have any pre-existing cardiac disease at the time of diagnosis of their breast cancer (2004-2011).
  • Pregnant and nursing women are ineligible.

Key Trial Info

Start Date :

June 27 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 26 2018

Estimated Enrollment :

201 Patients enrolled

Trial Details

Trial ID

NCT03235427

Start Date

June 27 2017

End Date

June 26 2018

Last Update

May 21 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northwell Health

Lake Success, New York, United States, 11042

The CAROLE (CArdiac Related Oncologic Late Effects) Study | DecenTrialz